Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
According to TipRanks, Maini is a 3-star analyst with an average return of 12.2% and a 75.00% success rate. Maini covers the Healthcare sector, focusing on stocks such as Sionna Therapeutics, Inc., Tenax Therapeutics, and Tectonic Therapeutic.
Currently, the analyst consensus on Tenax Therapeutics is a Strong Buy with an average price target of $31.50.
Based on Tenax Therapeutics’ latest earnings release for the quarter ending March 31, the company reported a quarterly GAAP net loss of $15.72 million. In comparison, last year the company had a GAAP net loss of $10.41 million
